XTics - A Gamified Enhancer of Non-Pharmacological Interventions in Tic Disorders
1 other identifier
interventional
35
1 country
1
Brief Summary
The investigators developed a neuroscientifically-informed gamified tic-therapy platform. The investigators previously identified tic-triggering elements in movies and video games. Next, the investigators employed these elements to generate and validate a gamified intervention protocol, which is based on a video game the investigators designed (called XTics). The study tests the efficacy of the gamified tool integrated in an exposure and response prevention (ERP) protocol to enhance both patient's compliance and clinical outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFirst Submitted
Initial submission to the registry
March 21, 2024
CompletedFirst Posted
Study publicly available on registry
April 4, 2024
CompletedApril 4, 2024
March 1, 2024
6 months
March 21, 2024
March 31, 2024
Conditions
Outcome Measures
Primary Outcomes (7)
The Tic Yale Global Tic Severity Scale (YGTSS)
A semi-structured clinical interview for assessment of tic severity administered to participants and parents. A clinician rates motor and vocal tics in terms of number, frequency, intensity, complexity and interference as well as overall related impairment over the preceding week. The investigators used YGTSS total tic severity scores.
Baseline (beginning of Week 1), after Phase 1 (beginning of Week 3), and after phase 2 (beginning of Week 5)
The Parent Tic Questionnaire (PTQ)
A parent-report instrument for assessing tic severity. Tics are rated by frequency and intensity, and are summed to reflect motor, vocal, and total tics scores. PTQ has good internal consistency, good to excellent 2-week temporal stability, and convergent and discriminant validity in a clinic sample.
Baseline, after Phase 1, after Phase 2, after the Booster phase (Week 7), and three months after the treatment termination
Premonitory Urge for Tic Scale (PUTS)
A self-report scale, which measures tic-related premonitory urges.
Baseline, after Phase 1, after Phase 2
The Subjective Units of Distress Scale (SUDS)
A self-reported questionnaire assessing the degree of inconvenience attributed to (1) tics and (2) the premonitory urges. Participants provided their ratings on a scale ranging from 0 (indicating absence) to 10 (indicating very severe). The total score was computed by summing the responses from both scales.
By the end of each training day
The "Urge Thermometer"
A momentary ratings of the experienced magnitude of premonitory urge. The scale consisted of five qualitative descriptions of "0- not at all", "1 - weak", "2 - medium", "3 - strong" and "4- very strong". The child was instructed to pick a number/description to indicate his/her current pre-tic urge
By the end of each training day
Rush Videotape Protocol
Based on the Rush Videotape Protocol, the investigators recorded the participants under two resting epochs (i.e., performing no specific task) where they were left alone in the room and were instructed to remain seated and wait for 2.5 minutes while avoiding tic suppression. Tics were counted offline by a human rater who also marks epochs in which the participant is hidden or moved in a way that violated the instructions. The investigators used the total Rush scores, which combine scores for tic frequency (number of motor and phonic tics divided by duration of valid recording) and severity of motor and phonic tics.
Week 1, Week 3, Week 5
Tic-to-tic interval
The duration between two subsequent tics
Week 1, Week 3
Secondary Outcomes (7)
The Screen for Child Anxiety Related Emotional Disorders (SCARED)
Week 1, Week 5
The Children Depression Inventory (CDI)
Baseline and after Phase 2
The Conners' Parent Rating Scale-Revised Long Form (CRS:RL)
Week 1, Week 5
Obsessive Compulsive Inventory-Child Version (OCI-CV)
Week 1, Week 5
The Behavior Rating Inventory of Executive Function (BRIEF)
Week 1, Week 5
- +2 more secondary outcomes
Study Arms (2)
Immediate and contingent reward (ICR)
EXPERIMENTALTic suppression directly affects gameplay, with participants informed that suppressing tics weakens opponents and improves card acquisition. Daily sessions end with feedback on suppression performance relative to that day's baseline.
Delayed reward (DR)
ACTIVE COMPARATORThe gameplay does not depend on performance, but participants still receive end-of-session feedback on tic suppression.
Interventions
XTics is a gamified protocol of behavioral treatment for tic disorders. The participant's tics are monitored in real-time and they are reflected as achievements in a game that the participant plays at the same time. The rewards aim to counteract processes that consolidate the tic. XTics is compatible with ERP treatment, and it includes an introductory psychoeducation session and three behavioral training sessions.
Eligibility Criteria
You may qualify if:
- Children and youths aged 7-15 years,
- At least moderate tic severity as indicated by a Yale Global Tic Severity Scale (YGTSS) tic severity score ≥ 11 and
- Tic frequency of over one tic per minute on average in the screening interview.
You may not qualify if:
- Behavioral treatment for tics in the past 12 months
- Pharmacological treatment for tics that has not been stable the for the past 6 weeks or with planned changes during study participation
- Evidence of tics that may produce physical harm to the child
- A history of psychiatric or neurological disorders requiring hospitalisation or a known cognitive decline.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sagol Brain Institute, Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gal Raz, PhD
Sagol Brain Institute, Tel Aviv Sourasky Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Personnel who interact directly with the study subjects were not aware of the assigned treatments. Personnel who analyze the data collected from the study are not aware of the treatment applied to any given group.
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2024
First Posted
April 4, 2024
Study Start
July 1, 2022
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
April 4, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share